RUA Life Sciences plc (AIM:RUA)

Market Cap	6.98M
Revenue (ttm)	4.11M
Net Income (ttm)	1,000.00
Shares Out	62.06M
EPS (ttm)	0.00
PE Ratio	6,981.78
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,911
Average Volume	219,679
Open	10.67
Previous Close	11.25
Day's Range	10.67 - 11.63
52-Week Range	10.33 - 15.70
Beta	0.83
RSI	37.05
Earnings Date	Sep 10, 2025

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates through Biomaterials, Contract Manufacture, Vascular, and Structural Heart segments. The Biomaterials segment operates as depository of the Intellectual Property and licensing rights to a range of biostable and implantable polymers, including Elast-Eon and ECSil. The Contract Manufacture segment provides sub-contract manufacturin...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 40
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: RUA